Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance

The predictive factors of long-term clinical benefits in patients with hepatitis C virus (HCV)—related liver cirrhosis after Direct Antiviral Agents (DAA) treatment are still undefined. The aim of this study was to identify any predictors of liver failure, hepatocellular carcinoma (HCC) and/or death...

Descripción completa

Detalles Bibliográficos
Autores principales: Franzè, Maria Stella, Filomia, Roberto, Caccamo, Gaia, Pitrone, Concetta, Alibrandi, Angela, Saitta, Carlo, Caspanello, Amalia Rita, Asero, Clelia, Arcadi, Vittoria, Raimondo, Giovanni, Cacciola, Irene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699534/
https://www.ncbi.nlm.nih.gov/pubmed/36579534
http://dx.doi.org/10.3390/jpm12111794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699534/
https://www.ncbi.nlm.nih.gov/pubmed/36579534
http://dx.doi.org/10.3390/jpm12111794

Ejemplares similares